Bill Text: IL HB5569 | 2023-2024 | 103rd General Assembly | Introduced

---

Bill Title: Amends the University of Illinois Hospital Act. Requires the University of Illinois Hospital to provide patients who overdose or have symptoms of opioid use disorder with an opioid antagonist upon discharge. Amends the Hospital Licensing Act. Requires hospitals licensed under the Act to provide patients who overdose or have symptoms of opioid use disorder with an opioid antagonist upon discharge.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced) 2024-02-09 - Referred to Rules Committee [HB5569 Detail]

Download: Illinois-2023-HB5569-Introduced.html

---

103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 HB5569 Introduced 2/9/2024, by Rep. Maura Hirschauer SYNOPSIS AS INTRODUCED:
110 ILCS 330/6.8 new
210 ILCS 85/6.35 new
Amends the University of Illinois Hospital Act. Requires the University of Illinois Hospital to provide patients who overdose or have symptoms of opioid use disorder with an opioid antagonist upon discharge. Amends the Hospital Licensing Act. Requires hospitals licensed under the Act to provide patients who overdose or have symptoms of opioid use disorder with an opioid antagonist upon discharge.
LRB103 38683 CES 68820 b
A BILL FOR
HB5569 LRB103 38683 CES 68820 b
AN ACT concerning regulation.
Be it enacted by the People of the State of Illinois,
represented in the General Assembly:
Section 5. The University of Illinois Hospital Act is
amended by adding Section 6.8 as follows:
(110 ILCS 330/6.8 new)
Sec. 6.8. Opioid antagonist. The University of Illinois
Hospital shall provide patients who overdose or have symptoms
of opioid use disorder with an opioid antagonist upon
discharge.
Section 10. The Hospital Licensing Act is amended by
adding Section 6.35 as follows: